Xenon anaesthesia for patients undergoing off-pump coronary artery bypass graft surgery: A prospective randomized controlled pilot trial

British Journal of Anaesthesia

Volumn 115, Issue 4, 2015, Pages 550-559

  Al Tmimi, L ^a   Van Hemelrijck, J ^a,b   Van De Velde, M ^a,b   Sergeant, P ^a,b   Meyns, B ^a,b   Missant, C ^a,b   Jochmans, I ^a   Poesen, K ^a,c   Coburn, M ^d   Rex, S ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

noradrenaline dose; OPCAB; postoperative delirium; sevoflurane anaesthesia; xenon anaesthesia

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LORAZEPAM; PIRITRAMIDE; PLASMA PROTEIN; PROPOFOL; PROTEIN S100B; SEVOFLURANE; SUFENTANIL; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; XENON; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; NORADRENALIN; VASOCONSTRICTOR AGENT;

ADULT; AGED; ANESTHESIA LEVEL; ARTERIAL PRESSURE; ARTICLE; BLOOD GAS ANALYSIS; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HEART INDEX; HEART OUTPUT; HUMAN; MALE; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PERIOPERATIVE PERIOD; PILOT STUDY; POSTOPERATIVE CARE; POSTOPERATIVE DELIRIUM; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SINGLE BLIND PROCEDURE; VENOUS OXYGEN TENSION; COMPARATIVE STUDY; DRUG EFFECTS; HEMODYNAMICS; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANESTHETICS, INHALATION; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HEMODYNAMICS; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; NOREPINEPHRINE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; VASOCONSTRICTOR AGENTS; XENON;

EID: 84943235324     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aev303     Document Type: Article

References (41)

1. Baumert JH, Falter F, Eletr D, Hecker KE, Reyle-Hahn M, Rossaint R. Xenon anaesthesia may preserve cardiovascular function in patients with heart failure. Acta Anaesthesiol Scand 2005; 49: 743-9
2. Coburn M. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth 2005; 94: 198-202
3. Rossaint R, Reyle-Hahn M, Schulte Am Esch J, et al. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003; 98: 6-13
4. Wappler F, Rossaint R, Baumert J, et al.Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery. Anesthesiology 2007; 106: 463-71
5. Hüneke R, Jüngling E, Skasa M, Rossaint R, Lückhoff A. Effects of the anesthetic gases xenon, halothane, and isoflurane on calcium and potassium currents in human atrial cardiomyocytes. Anesthesiology 2001; 95: 999
6. Schaefer W, Meyer PT, Rossaint R, et al. Myocardial blood flow during general anesthesia with xenon in humans. Anesthesiology 2011; 114: 1373-9
7. Grosse Hartlage MA, Berendes E, van Aken H, Fobker M, Theisen M, Weber TP. Xenon improves recovery from myocardial stunning in chronically instrumented dogs. Anesth Analg 2004; 99: 655-64
8. Roehl AB, Funcke S, Becker MM, et al. Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat. Anesthesiology 2013; 118: 1385-94
9. Chassot PG, van der Linden P, ZauggM,MuellerXM, Spahn DR. Off-pump coronary artery bypass surgery: physiology and anaesthetic management. Br J Anaesth 2004; 92: 400-13
10. Hanss R, Bein B, Turowski P, et al. The influence of xenon on regulation of the autonomic nervous system in patients at high risk of perioperative cardiac complications. Br J Anaesth 2006; 96: 427-36
11. Lamy A, Devereaux PJ, Prabhakaran D, et al. Off-pump or onpump coronary-artery bypass grafting at 30 days. N Engl J Med 2012; 366: 1489-97
12. Lockwood GG, Franks NP, Downie NA, Taylor KM, Maze M. Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study. Anesthesiology 2006; 104: 458-65
13. Stoppe C, Fahlenkamp AV, Rex S, et al. Feasibility and safety of xenon compared with sevoflurane anaesthesia in coronary surgical patients: A randomized controlled pilot study. Br J Anaesth 2013; 111: 406-16
14. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials 2010; 11: 32
15. Coburn M, Sanders RD, Maze M, Rossaint R. The Hip Fracture Surgery in Elderly Patients (HIPELD) study: protocol for a randomized, multicenter controlled trial evaluating the effect of xenon on postoperative delirium in older patients undergoing hip fracture surgery. Trials 2012; 13: 180
16. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98
17. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990; 113: 941-8
18. Yesavage JA, Sheikh JI. 9/Geriatric Depression Scale (GDS). Clin Gerontologist 1986; 5: 165-73
19. De Raet JM, DeSimone JP, Sergeant PT. Off-pump coronary artery bypass grafting: Anno 2011. Multimed Man Cardiothorac Surg 2011; 2011: mmcts.2004-000539
20. Stoppe C, Rimek A, Rossaint R, et al. Xenon consumption during general surgery: A retrospective observational study. Med Gas Res 2013; 3: 12
21. Le Gall J-R. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957
22. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-800
23. Avidan MS, Palanca BJ, Glick D, et al. Protocol for the BAG-RECALL clinical trial: A prospective, multi-center, randomized, controlled trial to determine whether a bispectral indexguided protocol is superior to an anesthesia gas-guided protocol in reducing intraoperative awareness with explicit recall in high risk surgical patients. BMC Anesthesiol 2009; 9: 8
24. Dixon JR. The international conference on harmonization good clinical practice guideline. Qual Assur 1998; 6: 65-74
25. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12
26. Ludbrook J. Repeated measurements and multiple comparisons incardiovascular research. Cardiovasc Res 1994; 28: 303-11
27. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 1998; 25: 1032-7
28. Machin D, Cheung YB, Parmar M. Survival Analysis: A Practical Approach, 2nd edn. New York: John Wiley & Sons, 2006
29. Sessler DI, Sigl JC, Kelley SD, et al. Hospital stay and mortality are increased in patients having a "triple low" of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia. Anesthesiology 2012; 116: 1195-203
30. Frey UH, Karlik J, Herbstreit F, Peters J. 2-Adrenoceptor gene variants affect vasopressor requirements in patients after thoracic epidural anaesthesia. Br J Anaesth 2014; 112: 477-84
31. Weis F, Kilger E, Beiras-Fernandez A, et al. Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 2006; 61: 938-42
32. Ma D, Lim T, Xu J, et al. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1α activation. J Am Soc Nephrol 2009; 20: 713-20
33. Doping Agency Bans Xenon and Argon. Chemical & Engineering News [Internet]. Available from http://cen.acs.org/articles/ 92/i23/Doping-Agency-Bans-Xenon-Argon.html (accessed 14 July 2014).
34. Inouye SK,Westendorp RGJ, Saczynski JS. Delirium in elderly people. Lancet 2014; 383: 911-22
35. Saczynski JS, Marcantonio ER, Quach L, et al. Cognitive trajectories after postoperative delirium. N Engl J Med 2012; 367: 30-9
36. Ma D, Yang H, Lynch J, FranksNP,Maze M, Grocott HP. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2003; 98: 690-8
37. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature 1998; 396: 324
38. Rex S, Meyer PT, Baumert JH, et al. Positron emission tomography study of regional cerebral blood flowand flow-metabolism coupling during general anaesthesia with xenon in humans. Br J Anaesth 2008; 100: 667-75
39. Ma D, Hossain M, Pettet GKJ, et al. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006; 26: 199-208
40. Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB. The neuroinflammatory hypothesis of delirium. Acta Neuropathol 2010; 119: 737-54
41. Ali MS, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth 2001; 86: 289-90